Crucell, National Institutes of Health deal

CRXL received a contract of up to $27.6 million from the NIH's Vaccine Research Center to manufacture an Ebola vaccine that uses CRXL's PER.C6 cell line. Under a 2002 CRADA, the Vaccine Research Cente...